PREVENT PRECLINICAL DRUG DEVELOPMENT PROGRAM: PRECLINICAL EFFICACY AND INTERMEDIATE BIOMARKERS; TASK ORDER: PREVENTION OF COLORECTAL CANCER WITH IPSC-BASED VACCINE

DELIVERY ORDER won by THE UNIVERISTY OF TEXAS M.D. ANDERSON CANCER CENTER · work in HOUSTON, TX
$635,712
RecipientTHE UNIVERISTY OF TEXAS M.D. ANDERSON CANCER CENTER UEI S3GMKS8ELA16
Award ID75N91021F00001
Award amount$635,712
Award typeDELIVERY ORDER
Awarding agencyDepartment of Health and Human Services — National Institutes of Health
NAICS541714 — RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)
PSCAN12
Start dateMay 12, 2021
End dateFeb 11, 2023
Place of performanceHOUSTON, TX
Record updatedSep 28, 2022

View the official award record

Our catalog shows awards of $250K+ active within the last 5 years. Need older history or smaller awards? Tell us what you need — we expand by request.

Awards tell you who won. Bids tell you what's next. BidCatch scans 100+ federal, state, and local sources every night and sends the new opportunities matching your trade — before they're awarded to someone else. Free for 14 days, then $49.99/month.

Search open bids